SEI Investments’s Design Therapeutics DSGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$422K Buy
33,603
+10,863
+48% +$150K ﹤0.01% 2716
2026
Q2
$329K Sell
22,740
-110,463
-83% -$1.38M ﹤0.01% 2822
2026
Q1
$1.42M Buy
133,203
+80,473
+153% +$814K ﹤0.01% 2180
2025
Q4
$495K Buy
+52,730
New +$413K ﹤0.01% 2510

Other funds holding DSGN

SEI Investments's DSGN Position: Q3 2026 in Review

SEI Investments increased its Design Therapeutics (DSGN) stake by 48% in Q3 2026, buying an estimated $150K and bringing the position to 33,603 shares worth $422K. The position accounts for ﹤0.01% of the portfolio, ranked #2716.

SEI Investments first reported a position in DSGN in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.42M in Q1 2026. 142 funds tracked by Wall St. Rank hold DSGN as of Q3 2026.

  • SEI Investments held 33,603 shares of Design Therapeutics worth $422K as of Q3 2026.
  • SEI Investments bought 10,863 Design Therapeutics shares in Q3 2026, an estimated $150K.
  • Design Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q3 2026, its #2716 holding.
  • SEI Investments first reported a position in Design Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • SEI Investments's Design Therapeutics position peaked at $1.42M in Q1 2026.
  • 142 funds tracked by Wall St. Rank held Design Therapeutics as of Q3 2026.

Based on SEI Investments's 13F filing for Q3 2026, filed 10 Nov 2026.